Shapiro Adam B, Jahić Haris, Gao Ning, Hajec Laurel, Rivin Olga
AstraZeneca R&D Boston, Waltham, Massachusetts, USA.
J Biomol Screen. 2012 Jun;17(5):662-72. doi: 10.1177/1087057112436885. Epub 2012 Feb 14.
Peptidoglycan biosynthesis is an essential process in bacteria and is therefore a suitable target for the discovery of new antibacterial drugs. One of the last cytoplasmic steps of peptidoglycan biosynthesis is catalyzed by the integral membrane protein MraY, which attaches soluble UDP-N-acetylmuramoyl-pentapeptide to the membrane-bound acceptor undecaprenyl phosphate. Although several natural product-derived inhibitors of MraY are known, none have the properties necessary to be of clinical use as antibacterial drugs. Here we describe a novel, homogeneous, fluorescence resonance energy transfer-based MraY assay that is suitable for high-throughput screening for novel MraY inhibitors. The assay allows for continuous measurement, or it can be quenched prior to measurement.
肽聚糖生物合成是细菌中的一个重要过程,因此是发现新型抗菌药物的合适靶点。肽聚糖生物合成的最后一个胞质步骤之一由整合膜蛋白MraY催化,该蛋白将可溶性UDP-N-乙酰胞壁酰五肽连接到膜结合的受体十一异戊烯磷酸上。尽管已知几种源自天然产物的MraY抑制剂,但没有一种具有作为抗菌药物临床使用所需的特性。在此,我们描述了一种基于荧光共振能量转移的新型、均相MraY检测方法,该方法适用于高通量筛选新型MraY抑制剂。该检测方法可以进行连续测量,也可以在测量前淬灭。